Effectiveness of whole-body magnetic resonance imaging for the efficacy of biologic anti-rheumatic drugs in patients with rheumatoid arthritis: A retrospective pilot study

References

• Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, 3rd, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62:2569–81.
   PubMed Web of Science ®Google Scholar
• Smolen JS, Landewe R, Breedveld FC, Buch M, Burmester G, Dougados M, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis. 2014;73:492–509.
   PubMed Web of Science ®Google Scholar
• Haraoui B, Smolen JS, Aletaha D, Breedveld FC, Burmester G, Codreanu C, et al. Treating rheumatoid arthritis to target: multinational recommendations assessment questionnaire. Ann Rheum Dis. 2011;70:1999–2002.
   PubMed Web of Science ®Google Scholar
• Colebatch AN, Edwards CJ, Ostergaard M, van der Heijde D, Balint PV, D'Agostino MA, et al. EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Ann Rheum Dis. 2013;72:804–14.
   PubMed Web of Science ®Google Scholar
• Baillet A, Gaujoux-Viala C, Mouterde G, Pham T, Tebib J, Saraux A, et al. Comparison of the efficacy of sonography, magnetic resonance imaging and conventional radiography for the detection of bone erosions in rheumatoid arthritis patients: a systematic review and meta-analysis. Rheumatology (Oxford). 2011;50:1137–47.
   PubMed Web of Science ®Google Scholar
• Szkudlarek M, Terslev L, Wakefield RJ, Backhaus M, Balint PV, Bruyn GA, et al. Summary findings of a systematic literature review of the ultrasound assessment of bone erosions in rheumatoid arthritis. J Rheumatol. 2016;43:12–21.
   PubMed Web of Science ®Google Scholar
• Hetland ML, Ejbjerg B, Horslev-Petersen K, Jacobsen S, Vestergaard A, Jurik AG, et al. MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA). Ann Rheum Dis. 2009;68:384–90.
   PubMed Web of Science ®Google Scholar
• Hetland ML, Stengaard-Pedersen K, Junker P, Ostergaard M, Ejbjerg BJ, Jacobsen S, et al. Radiographic progression and remission rates in early rheumatoid arthritis – MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial. Ann Rheum Dis. 2010;69:1789–95.
   PubMed Web of Science ®Google Scholar
• Nakashima Y, Tamai M, Kita J, Michitsuji T, Shimizu T, Fukui S, et al. Magnetic resonance imaging bone edema at enrollment predicts rapid radiographic progression in patients with early RA: results from the Nagasaki University Early Arthritis Cohort. J Rheumatol. 2016;43:1278–84.
   PubMed Web of Science ®Google Scholar
• Kamishima T, Fujieda Y, Atsumi T, Mimura R, Koike T, Terae S, et al. Contrast-enhanced whole-body joint MRI in patients with unclassified arthritis who develop early rheumatoid arthritis within 2 years: feasibility study and correlation with MRI findings of the hands. AJR Am J Roentgenol. 2010;195:W287–92.
   PubMed Web of Science ®Google Scholar
• Schmidt WA. Imaging: whole-body MRI in RA: do we still need the rheumatologist? Nat Rev Rheumatol. 2014;10:130–2.
   PubMed Web of Science ®Google Scholar
• Ogishima H, Tsuboi H, Umeda N, Horikoshi M, Kondo Y, Sugihara M, et al. Analysis of subclinical synovitis detected by ultrasonography and low-field magnetic resonance imaging in patients with rheumatoid arthritis. Mod Rheumatol. 2014;24:60–8.
   PubMed Web of Science ®Google Scholar
• Kawashiri SY, Suzuki T, Nakashima Y, Horai Y, Okada A, Iwamoto N, et al. Confirmation of effectiveness of tocilizumab by ultrasonography and magnetic resonance imaging in biologic agent-naive early-stage rheumatoid arthritis patients. Mod Rheumatol. 2015;25:948–53.
   PubMed Web of Science ®Google Scholar
• Hirota T, Suzuki T, Ogishima H, Hagiwara S, Ebe H, Takahashi H, et al. Evaluation of changes in magnetic resonance images following 24 and 52 weeks of treatment of rheumatoid arthritis with infliximab, tocilizumab, or abatacept. Mod Rheumatol. 2016;26:29–35.
   PubMed Web of Science ®Google Scholar
• Axelsen MB, Eshed I, Duer-Jensen A, Moller JM, Pedersen SJ, Ostergaard M. Whole-body MRI assessment of disease activity and structural damage in rheumatoid arthritis: first step towards an MRI joint count. Rheumatology (Oxford). 2014;53:845–53.
   PubMed Web of Science ®Google Scholar
• Sharp JT, Bluhm GB, Brook A, Brower AC, Corbett M, Decker JL, et al. Reproducibility of multiple-observer scoring of radiologic abnormalities in the hands and wrists of patients with rheumatoid arthritis. Arthritis Rheum. 1985;28:16–24.
   PubMed Web of Science ®Google Scholar
• Aletaha D, Smolen JS. The definition and measurement of disease modification in inflammatory rheumatic diseases. Rheum Dis Clin N Am. 2006;32:9–44. vii.
   PubMed Web of Science ®Google Scholar
• Ostergaard M, Edmonds J, McQueen F, Peterfy C, Lassere M, Ejbjerg B, et al. An introduction to the EULAR-OMERACT rheumatoid arthritis MRI reference image atlas. Ann Rheum Dis. 2005;64Suppl.1:i3–7.
   Web of Science ®Google Scholar
• Ostergaard M, Peterfy C, Conaghan P, McQueen F, Bird P, Ejbjerg B, et al. OMERACT rheumatoid arthritis magnetic resonance imaging studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system. J Rheumatol. 2003;30:1385–6.
   PubMed Web of Science ®Google Scholar
• Kamishima T, Kato M, Atsumi T, Koike T, Onodera Y, Terae S. Contrast-enhanced whole body joint MR imaging in rheumatoid patients on tumour necrosis factor-alpha agents: a pilot study to evaluate novel scoring system for MR synovitis. Clin Exp Rheumatol. 2013;31:154.
   PubMed Web of Science ®Google Scholar
• Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–74.
   PubMed Web of Science ®Google Scholar
• Haavardsholm EA, Boyesen P, Ostergaard M, Schildvold A, Kvien TK. Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow oedema predicts erosive progression. Ann Rheum Dis. 2008;67:794–800.
   PubMed Web of Science ®Google Scholar
• McQueen FM, Benton N, Perry D, Crabbe J, Robinson E, Yeoman S, et al. Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later in patients with rheumatoid arthritis. Arthritis Rheum. 2003;48:1814–27.
   PubMed Web of Science ®Google Scholar
• Lisbona MP, Pamies A, Ares J, Almirall M, Navallas M, Solano A, et al. Association of bone edema with the progression of bone erosions quantified by hand magnetic resonance imaging in patients with rheumatoid arthritis in remission. J Rheumatol. 2014;41:1623–9.
   PubMed Web of Science ®Google Scholar
• Kita J, Tamai M, Arima K, Kawashiri SY, Horai Y, Iwamoto N, et al. Significant improvement in MRI-proven bone edema is associated with protection from structural damage in very early RA patients managed using the tight control approach. Mod Rheumatol. 2013;23:254–9.
   PubMed Web of Science ®Google Scholar
• Jimenez-Boj E, Nobauer-Huhmann I, Hanslik-Schnabel B, Dorotka R, Wanivenhaus AH, Kainberger F, et al. Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritis. Arthritis Rheum. 2007;56:1118–24.
   PubMed Web of Science ®Google Scholar
• Teruel JR, Burghardt AJ, Rivoire J, Srikhum W, Noworolski SM, Link TM, et al. Bone structure and perfusion quantification of bone marrow edema pattern in the wrist of patients with rheumatoid arthritis: a multimodality study. J Rheumatol. 2014;41:1766–73.
   PubMed Web of Science ®Google Scholar